2-amino-N-butyl-3-phenylpropanamide | 123673-69-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 2-amino-N-butyl-3-phenylpropanamide
• CAS: 123673-69-8
• 化学式: C₁₃H₂₀N₂O
• mdl: MFCD09933433
• 分子量: 220.315
• InChiKey: LBYVHWXCOKDORT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  6
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.461
• 拓扑面积：
  55.1
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-amino-N-butyl-3-phenylpropanamide 、 丙酮 以 甲醇 为溶剂， 反应 24.0h， 以10.26 g的产率得到5-benzyl-3-butyl-2,2-dimethylimidazolidin-4-one
  参考文献：
  名称：

  A Click Strategy for the Immobilization of MacMillan Organocatalysts onto Polymers and Magnetic Nanoparticles

  摘要：

  A chemically modified, first generation MacMillan imidazolidin-4-one has been anchored onto 1% DVB Merrifield resin and Fe3O4 (5.3 +/- 1.4 nm) magnetic nanoparticles through copper-catalyzed alkyne azide cycloaddition (CuAAC) reactions. The resulting immobilized catalysts have been successfully used in the asymmetric Friedel-Crafts alkylation of N-substituted pyrroles with alpha,beta-unsaturated aldehydes. The PS-supported catalyst (B) showed higher catalytic activity and enantioselectivity, while the MNP-supported one (A) showed higher recyclability and could be used in a sequential process with intermediate magnetic decantation.

  DOI：

  10.1021/ol301515d
• 作为产物：
  描述：

  正丁胺 、 DL-苯基丙氨酸甲酯盐酸盐 反应 24.0h， 生成 2-amino-N-butyl-3-phenylpropanamide
  参考文献：
  名称：

  A Click Strategy for the Immobilization of MacMillan Organocatalysts onto Polymers and Magnetic Nanoparticles

  摘要：

  A chemically modified, first generation MacMillan imidazolidin-4-one has been anchored onto 1% DVB Merrifield resin and Fe3O4 (5.3 +/- 1.4 nm) magnetic nanoparticles through copper-catalyzed alkyne azide cycloaddition (CuAAC) reactions. The resulting immobilized catalysts have been successfully used in the asymmetric Friedel-Crafts alkylation of N-substituted pyrroles with alpha,beta-unsaturated aldehydes. The PS-supported catalyst (B) showed higher catalytic activity and enantioselectivity, while the MNP-supported one (A) showed higher recyclability and could be used in a sequential process with intermediate magnetic decantation.

  DOI：

  10.1021/ol301515d

文献信息

• Pd-Catalysed oxidative carbonylation of α-amino amides to hydantoins under mild conditions
  作者：Aleksandr Voronov、Vinayak Botla、Luca Montanari、Carla Carfagna、Raffaella Mancuso、Bartolo Gabriele、Giovanni Maestri、Elena Motti、Nicola Della Ca

  DOI：10.1039/d1cc04154a

  日期：——

  The first example of palladium-catalysed oxidative carbonylation of unprotected α-amino amides to hydantoins is described here. The selective synthesis of the target compounds was achieved under mild conditions (1 atm of CO), without ligands and bases. The catalytic system overrode the common reaction pathway that usually leads instead to the formation of symmetrical ureas.

  这里描述了钯催化氧化羰基化未保护的 α-氨基酰胺为乙内酰脲的第一个例子。目标化合物的选择性合成是在温和条件下（1 atm CO）实现的，无需配体和碱。催化系统超越了通常导致形成对称尿素的常见反应途径。
• FATTY ACID DERIVATIVES FOR ORAL ADMINISTRATION ENDOWED WITH HIGH PALATABILITY
  申请人：Berni Canani Roberto

  公开号：US20110098319A1

  公开（公告）日：2011-04-28

  The invention relates to novel derivatives of short-chain fatty acids, in particular derivatives of butyric acid, useful for all the known clinical applications of the latter, which show physicochemical characteristics suitable for an easy oral administration, being devoid of the unpleasant organoleptic properties that characterize butyrate. The new compounds are amide derivatives which can be synthesized by reaction of the corresponding fatty acid halide with a naturally occurring amino acid, phenylalanine or a suitable derivative thereof, and which are in a poorly hygroscopic, easily weighable form, stable to acids and alkalis and able to release the acid at the small and large bowel level in a constant manner over time. They do not have disagreeable odors and are practically tasteless, thus allowing the manufacture of preparations for oral administration also suitable for the therapy of chronic diseases and in the pediatric field.

  本发明涉及一种新型的短链脂肪酸衍生物，特别是丁酸衍生物，适用于后者的所有已知临床应用，具有适合易于口服的物理化学特性，不具有表征丁酸的不愉快的感官特性。新的化合物是酰胺衍生物，可以通过相应的脂肪酸卤化物与天然存在的氨基酸苯丙氨酸或其适当衍生物反应合成，并且以不易吸湿，易于称重的形式存在，对酸和碱稳定，并且能够在时间上以恒定的方式释放酸到小肠和大肠水平。它们没有不愉快的气味，几乎没有味道，因此可以制备适合于口服治疗慢性疾病和儿科领域的制剂。
• [EN] SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS<br/>[FR] (INDOLE-2-CARBONYL-)-GLYCINAMIDES SUBSTITUES EN N ET LEURS DERIVES, SERVANT D'INHIBITEURS DE LA GLYCOGENE PHOSPHORYLASE
  申请人：PFIZER, INC.

  公开号：WO1996039384A1

  公开（公告）日：1996-12-12

  (EN) Compounds of Formula (1) wherein R6 is carboxy, (C1-C8)alkoxycarbonyl, benzyloxycarbonyl, C(O)NR8R9 or C(O)R12 as glucogen phosphorylase inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to treat diabetes, hyperglycemia, hypercholesterolemia, hypertension, hyperinsulinemia, hyperlipidemia, atherosclerosis and myocardial ischemia in mammals.(FR) L'invention concerne des composés de formule (1) où R6 représente carboxy, alcoxycarbonyle (C1-C8), benzyloxycarbonyle, C(O)NR8R9 ou C(O)R12, servant d'inhibiteurs de la glycogène phosphorylase, ainsi que des compositions pharmaceutiques contenant ces inhibiteurs. L'invention concerne également l'utilisation de ces inhibiteurs pour le traitement du diabète, de l'hyperglycémie, de l'hypercholestérolémie, de l'hypertension, de l'hyperinsulinémie, de l'hyperlipidémie, de l'athérosclérose et de l'ischème myocardiaque chez les mammifères.

  化合物的化学式为(1)，其中R6代表羧基、(C1-C8)烷氧羰基、苄氧羰基、C(O)NR8R9或C(O)R12，作为糖原磷酸化酶抑制剂，含有这种抑制剂的制药组合物以及使用这种抑制剂治疗哺乳动物的糖尿病、高血糖、高胆固醇血症、高血压、高胰岛素血症、高脂血症、动脉粥样硬化和心肌缺血的方法。
• Process for the preparation of substituted N-(indole-2-carbonyl)- glycinamides
  申请人：PFIZER INC.

  公开号：EP1134213B1

  公开（公告）日：2005-11-02
• SUBSTITUTED N-(INDOLE-2-CARBONYL)-GLYCINAMIDES AND DERIVATIVES AS GLYCOGEN PHOSPHORYLASE INHIBITORS
  申请人：PFIZER INC.

  公开号：EP0832065B1

  公开（公告）日：2001-10-10